BioMarin Pharmaceutical Ownership | Who Owns BioMarin Pharmaceutical?


OverviewForecastRevenueFinancialsChartTranscripts

BioMarin Pharmaceutical Ownership Summary


BioMarin Pharmaceutical is owned by 62.82% institutional investors, 0.75% insiders, and 36.44% retail investors. Blackrock is the largest institutional shareholder, holding 12.04% of BMRN shares. Dodge & Cox Stock I is the top mutual fund, with 5.08% of its assets in BioMarin Pharmaceutical shares.

BMRN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioMarin Pharmaceutical62.82%0.75%36.44%
SectorHealthcare Stocks 232.64%10.66%-143.30%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock22.74M12.04%$1.87B
Blackrock funding, inc. /de19.14M9.98%$1.14B
Vanguard group18.13M9.46%$1.08B
Dodge & cox14.69M7.67%$795.44M
Primecap management co/ca/14.55M7.59%$864.67M
State street8.76M4.58%$474.69M
Viking global investors lp8.32M4.35%$450.73M
Norges bank7.53M3.93%$447.57M
Geode capital management3.67M1.92%$218.39M
Dimensional fund advisors lp3.32M1.73%$197.40M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management405.45K9.36%$21.96M
Palo alto investors lp754.01K7.56%$40.84M
Boone capital management328.55K5.83%$17.79M
Eagle health investments lp366.81K4.79%$21.80M
Camber capital management lp600.00K3.10%$32.98M
Sio capital management225.11K3.09%$12.19M
Diadema partners lp212.88K2.95%$11.53M
Soleus capital management1.32M2.89%$78.45M
Sector gamma as198.50K2.69%$11.80M
Novo660.00K2.30%$35.75M

Top Buyers

HolderShares% AssetsChange
Blackrock22.74M0.04%8.26M
Norges bank7.53M0.05%7.53M
Dimensional fund advisors lp3.32M0.04%1.08M
Assenagon asset management1.42M0.12%1.07M
Morgan stanley2.32M0.01%935.18K

Top Sellers

HolderShares% AssetsChange
Viking global investors lp8.32M1.17%-3.97M
Elliott investment management---3.50M
Blackrock funding, inc. /de19.14M0.02%-2.91M
Goldman sachs group454.91K0.00%-1.84M
Avoro capital advisors---1.46M

New Positions

HolderShares% AssetsChangeValue
Norges bank7.53M0.05%7.53M$447.57M
Braidwell lp528.00K0.85%528.00K$28.60M
Jefferies financial group467.02K0.14%467.02K$27.75M
Krensavage asset management405.45K9.36%405.45K$21.96M
Axa investment managers362.95K0.05%362.95K$19.66M

Sold Out

HolderChange
Cornerstone planning group-1.00
Blume capital management-2.00
Advisornet financial-3.00
Householder group estate & retirement specialist-3.00
Raleigh capital management-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025386-36.30%120,381,244-32.95%620.71%173-43.09%149-25.13%
Sep 30, 2025521-13.60%148,245,021-13.91%770.96%255-20.56%182-1.62%
Jun 30, 2025611-0.97%183,457,4080.41%951.05%322-5.57%1886.82%
Mar 31, 202511-98.11%305,544-99.83%-0.00%7-97.61%1-99.45%
Dec 31, 2024565-5.04%182,776,8923.30%951.11%2852.15%178-10.55%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Dodge & Cox Stock I9.77M5.08%-
American Funds Growth Fund of Amer A8.28M4.32%741.56K
Capital Group Growth Fnd of Amer Comp8.28M4.32%741.56K
iShares Core S&P Mid-Cap ETF6.20M3.23%182.30K
Vanguard Total Stock Mkt Idx Inv6.07M3.15%13.56K
Vanguard US Total Market Shares ETF6.04M3.15%4.43K
Vanguard PRIMECAP Inv5.29M2.75%-175.68K
Vanguard Capital Opportunity Inv5.21M2.71%-64.48K
VA CollegeAmerica Amcap 529A4.49M2.36%-115.70K
American Funds AMCAP A4.49M2.36%-115.70K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 11, 2026Guyer Charles Greg EVP, Chief Technical OfficerSell$996.74K
Feb 26, 2026Friberg Gregory R EVP, Chief R&D OfficerSell$381.94K
Feb 26, 2026Davis George Eric EVP, Chief Legal OfficerSell$1.60M
May 20, 2025Burkhart Erin GVP, Chief Accounting OfficerSell$105.93K
May 02, 2025Hubbard Cristin EVP, Chief Commercial OfficerSell$17.72K

Insider Transactions Trends


DateBuySell
2026 Q1-3
2025 Q4--
2025 Q3--
2025 Q2-2
2025 Q1-3

BMRN Ownership FAQ


Who Owns BioMarin Pharmaceutical?

BioMarin Pharmaceutical shareholders are primarily institutional investors at 62.82%, followed by 0.75% insiders and 36.43% retail investors. The average institutional ownership in BioMarin Pharmaceutical's industry, Biotech Stocks , is 382.13%, which BioMarin Pharmaceutical falls below.

Who owns the most shares of BioMarin Pharmaceutical?

BioMarin Pharmaceutical’s largest shareholders are Blackrock (22.74M shares, 12.04%), Blackrock funding, inc. /de (19.14M shares, 9.98%), and Vanguard group (18.13M shares, 9.46%). Together, they hold 31.48% of BioMarin Pharmaceutical’s total shares outstanding.

Does Blackrock own BioMarin Pharmaceutical?

Yes, BlackRock owns 12.04% of BioMarin Pharmaceutical, totaling 22.74M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.87B$. In the last quarter, BlackRock increased its holdings by 8.26M shares, a 57.05% change.

Who is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is BioMarin Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 9.36% of its assets in 405.45K BioMarin Pharmaceutical shares, valued at 21.96M$.

Who is the top mutual fund holder of BioMarin Pharmaceutical shares?

Dodge & Cox Stock I is the top mutual fund holder of BioMarin Pharmaceutical shares, with 5.08% of its total shares outstanding invested in 9.77M BioMarin Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools